Flunarizine Di HCL is a high-purity active pharmaceutical ingredient (API) manufactured to meet the exacting standards of multiple international pharmacopeias, including IP, BP, EP, and USP, with specific grades available for injectable formulations. Sourced from an FDA-approved manufacturing facility with a legacy dating back to 1971, this calcium channel blocker offers pharmaceutical companies a reliable and consistently available bulk ingredient. The commitment to quality is demonstrated through rigorous control processes and comprehensive documentation, ensuring every batch meets predefined specifications for purity, potency, and safety, making it a trustworthy foundation for critical drug production.
This API is integral to the pharmaceutical industry, specifically within the neurology and cardiology sectors. Manufacturers of generic medicines, specialty neurological drugs, and hospital-ready formulations utilize Flunarizine Di HCL for its proven role in migraine prophylaxis and ...
Flunarizine Di HCL is a high-purity active pharmaceutical ingredient (API) manufactured to meet the exacting standards of multiple international pharmacopeias, including IP, BP, EP, and USP, with specific grades available for injectable formulations. Sourced from an FDA-approved manufacturing facility with a legacy dating back to 1971, this calcium channel blocker offers pharmaceutical companies a reliable and consistently available bulk ingredient. The commitment to quality is demonstrated through rigorous control processes and comprehensive documentation, ensuring every batch meets predefined specifications for purity, potency, and safety, making it a trustworthy foundation for critical drug production.
This API is integral to the pharmaceutical industry, specifically within the neurology and cardiology sectors. Manufacturers of generic medicines, specialty neurological drugs, and hospital-ready formulations utilize Flunarizine Di HCL for its proven role in migraine prophylaxis and the treatment of vestibular disorders like vertigo. Its compliance with globally recognized pharmacopeial standards facilitates its use in products intended for regulated markets across North America, Europe, and Asia-Pacific, supporting companies in their regulatory submissions and market expansion efforts with a well-documented and certified ingredient.
Choosing this Flunarizine Di HCL API translates into tangible business value through supply chain reliability and reduced compliance risk. The long-standing operational history ensures not just product consistency but also dependable logistics and ready stock for immediate shipment, minimizing production delays. This reliability, combined with the economic advantage of competitive bulk pricing, allows manufacturers to focus on formulation and scaling, confident in the quality and regulatory acceptance of their core active ingredient. The result is a streamlined path to market for effective, safe medications.
Key Features:
- Manufactured in multiple pharmacopeial grades: IP, BP, EP, USP, and injectable.
- Produced in an FDA-approved facility with a proven track record since 1971.
- Ready stock is maintained for prompt order fulfillment and shipment.
- Guaranteed batch-to-batch consistency in purity and performance.
- Supported by complete quality documentation and certificates of analysis.
Benefits:
- Ensures compliance with international regulatory standards for global market access.
- Provides supply chain certainty with immediate availability from ready stock.
- Reduces manufacturing risk through guaranteed ingredient consistency and quality.
- Offers competitive value for bulk procurement in large-scale production.
- Delivers peace of mind with comprehensive traceability and documentation support.